CD33 and acute promyelocytic leukemia: Therefore, in order to identify a cellular target for PML-RARA that effectively develops APL, PML-RARA was transduced into fractionated cells: CD34+/CD38−, CD34+/CD38+ and CD34−/CD33+ cells from the cord blood (Figures 6A and 6B).